Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.
More info

FONDAZIONE MENARINI

A non-profit institution founded in 1976 to promote research...

GO TO SITE

MENARINI IN ASIA-PACIFIC

Find our companies

FEATURED

Latest News

September 21 2023

European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

Read More
September 13 2023

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf® in Taiwan and select South-East Asian markets

Read More
July 21 2023

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

Read More
July 06 2023

Fair Play Menarini International Awards, the champions of Fair Play cast their spell on the audience in Fiesole

Read More
July 03 2023

Fair Play Menarini International Awards, the 2023 edition starts with the talk show “The Champions tell their Stories” in Piazza della Signoria, Florence

Read More
© 2023 Menarini Asia-Pacific Pte Ltd | All rights reserved